About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Quant Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSMS Pharmaceuticals Limited9.6572114521736.5553
Domestic EquitiesSequent Scientific Limited8.7200147712633.0079
Domestic EquitiesAster DM Healthcare Limited7.852444667129.7237
Domestic EquitiesZydus Wellness Ltd7.297564173027.6233
Domestic EquitiesAurobindo Pharma Limited7.042021730026.6562
Domestic EquitiesPfizer Ltd6.30264795423.8571
Domestic EquitiesAlivus Life Sciences5.846324629822.1299
Domestic EquitiesAdani Enterprises Limited5.72249499621.6610
Domestic EquitiesANTHEM BIOSCIENCES LIMITED5.592933355421.1707
Domestic EquitiesSun Pharmaceutical Industries Limited4.80079921418.1720
Domestic EquitiesDivi's Laboratories Limited3.49472042413.2286
Domestic EquitiesConcord Biotech Limited3.12608347211.8330
Domestic EquitiesGodrej Properties Limited2.6264470159.9418
Domestic EquitiesGland Pharma Limited1.3051280764.9403
Total 79.3861 300.5008
Cash & Cash Equivalents and Net AssetsTREPS 01-Dec-2025 DEPO 1013.43435086850.8529
Cash & Cash Equivalents and Net AssetsNCA-NET CURRENT ASSETS-16.7712 -63.4841
Total -3.3369 -12.6312
Treasury Bills91 Days Treasury Bill 18-Dec-20251.84427000006.9808
Treasury Bills182 Days Treasury Bill 29-Jan-20261.83287000006.9376
Treasury Bills91 Days Treasury Bill 04-Dec-20250.79203000002.9978
Treasury Bills91 Days Treasury Bill 02-Jan-20260.78863000002.9851
Treasury Bills91 Days Treasury Bill 15-Jan-20260.78713000002.9794
Treasury Bills91 Days Treasury Bill 26-Feb-20260.78243000002.9616
Treasury Bills91 Days Treasury Bill 23-Jan-20260.52412000001.9839
Treasury Bills91 Days Treasury Bill 06-Feb-20260.26161000000.9901
Total 7.6127 28.8163
Derivatives-FuturesCipla Limited 30/12/20259.771724000036.9888
Derivatives-FuturesDivi's Laboratories Limited 30/12/20252.84141650010.7555
Derivatives-FuturesAurobindo Pharma Limited 30/12/20252.68058250010.1467
Derivatives-FuturesSamvardhana Motherson International Ltd 30/12/20250.91132952003.4494
Total 16.2049 61.3404
RightsAdani Enterprises Limited Rights0.1332113990.5043
Total 0.1332 0.5043
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.